The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close update

10 Feb 2020 07:00

RNS Number : 4117C
Watchstone Group PLC
10 February 2020
 

Watchstone Group plc

 

("Watchstone" or the "Group")

 

Pre-close update

 

Watchstone Group plc (LON:WTG) today issues a pre-close update ahead of its results for the year ended 31 December 2019.

 

During 2019, the Board continued its work to simplify the Group, resolve legacy issues, reduce costs and to commence the process for returning further capital to shareholders.

 

As announced on 7 February 2020, our Healthcare Services division in Canada was sold for an initial cash consideration of Canadian $36.2m (£20.8m) on a cash and debt free basis with up to a further C$0.8m (£0.5m) conditional on the business generating target revenues in the first year after its acquisition.

 

A number of commercial disputes were resolved in the year, the most significant of which was the High Court claim issued by Slater and Gordon (UK) 1 Limited ("S&G"). As announced on 21 October 2019, the settlement provided for £11m of the £50m held in escrow to be released to S&G with the balance of £39m and accrued interest being released to Watchstone.

 

Cash and term deposits on 31 December 2019 (excluding cash within businesses classified as held for sale) totalled £71.6m. Total cash following completion of the sale of the Healthcare Services division, is approximately £90m representing approximately 195 pence per share.

 

Capital return

 

Watchstone will now proceed with plans for a further Court approved, capital repayment to shareholders and further details will be announced in due course. Subject to shareholder approval, completion of the necessary working capital and creditor analysis (including contingent creditors) and the Court timetable, the current plan is to return at least £50m (representing at least 110p per share) before the end of June 2020. The timetable is anticipated to be slightly longer than usual given the need to complete the audit in advance of the return.

 

As further matters are resolved, the Company will seek to return additional cash to shareholders.

 

ingenie

 

Following the sale of the Healthcare Services division, Watchstone now retains one remaining operating business, ingenie. Consistent with our announcement at the half year, ingenie's retail business continued to face difficult market conditions in 2019, but significant changes have been made to increase competitiveness which are now bearing fruit with daily new policy sales at their highest levels for a number of years.

 

In November 2019, ingenie successfully launched its new self-fit proposition making its offering ever more competitive.

 

Legacy matters

 

The SFO investigation continues and we are cooperating fully. It remains the only regulatory inquiry to which the Group is subject.

 

Whilst we understand that the previously threatened class action litigation first announced in September 2015 has been abandoned, a firm purporting to act for a group of twelve individuals (some of whom participated in the original threatened litigation) has recently written a "Notice of intended claim" to the Company ("Notice"). The Notice relates to potential pursuit of a claim arising under section 90A and Schedule 10A of the Financial Services and Markets Act 2000. However, it provides no information to support the validity or valuation of the individual prospective claimants' claims, which they would be required to prove in due course in any litigation. The Company will vigorously defend all such claims if so brought.

 

2020 outlook

 

The Group's stated strategy remains to ultimately divest of its operating businesses, resolve all legacy issues and return as much capital as possible to shareholders.

 

The Board hopes that 2020 will see significant further progress to the final resolution of the Group's historic matters and a substantial return of capital to shareholders in at least one distribution (as referred to above).

 

For further information:

Watchstone Group plc 

 

 

Tel: 03333 448048

WH Ireland Limited, Nominated Adviser and broker

 

Chris Hardie

Lydia Zychowska

Tel: 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKZGGZLLNGGZM
Date   Source Headline
30th Nov 20127:00 amRNSQuindell awarded TM Forum's Certification Mark
16th Nov 20127:00 amRNSRecognition in Celent Report
15th Nov 20127:00 amRNSQuindell Earns High Ranking Among Industry Peers
14th Nov 20127:00 amRNSEquity placing for organic growth
12th Nov 20127:00 amRNSAward Success at Quindell
7th Nov 20127:00 amRNSProperty Claims Contract Win
6th Nov 201212:46 pmRNSNotification of Major Interest in Shares
5th Nov 20127:00 amRNSQuindell & NTT Data partner
2nd Nov 20127:01 amRNSRobert Thomson Appointment Confirmed
2nd Nov 20127:00 amRNSPlacing to raise £26.5 million
1st Nov 20127:00 amRNSIssue of Warrants
29th Oct 20122:35 pmRNSTrading Update
25th Oct 20127:00 amRNSQuindell recognised in Celent Claims report
15th Oct 20127:01 amRNSQ3 Trading Statement & Advisory Board Appointment
15th Oct 20127:00 amRNSAgreement with Pinto Potts Solicitors
10th Oct 20127:00 amRNSAcquisition of Metaskil
26th Sep 20127:00 amRNSAcquisition and Increase in Director Shareholding
18th Sep 20127:00 amRNSMajor Contract Win and Acquisition
4th Sep 20127:01 amRNSInterim Results
4th Sep 20127:00 amRNSExercise of Warrants
15th Aug 20127:00 amRNSCompletion of Acquisition and Strategy Update
13th Aug 20127:10 amRNSNotice of Results
13th Aug 20127:00 amRNSNotice of Analyst and Investor Teach-in
9th Jul 20127:00 amRNSPre Close Trading Statement
4th Jul 20127:00 amRNSUpdate on Software & Consulting division
29th Jun 201211:00 amRNSResult of AGM
28th Jun 20127:00 amRNSAnnual Report and Accounts
27th Jun 20127:00 amRNSFurther Agreement and Update on Silverbeck Rymer
15th Jun 20127:00 amRNSCommercial Agreement and Acquisition Terms
14th Jun 20127:00 amRNSRecommended Mandatory Cash Offer for Ai Claims
30th May 20127:00 amRNSDirector/PDMR Shareholding
24th May 20127:00 amRNSQuindell extends its technology capability
16th May 201211:28 amRNSForm 8 (DD) - [Quindell Portfolio]
15th May 20125:40 pmRNSOffer Update and Unconditional in all respects
15th May 201211:37 amRNSForm 8 (DD) - [Quindell Portfolio]
14th May 201210:12 amRNSForm 8 (DD) - [Quindell Portfolio]
14th May 20127:00 amRNSAppointment and acquisition
11th May 20121:44 pmRNSForm 8.3 - QUINDELL PORTFOLIO
11th May 201212:57 pmRNSForm 8.3 - Quindell Portfolio plc Replacement
11th May 201212:13 pmRNSForm 8.3 - Quindell Portfolio plc
11th May 201210:59 amRNSForm 8 (DD) - Quindell Portfolio
10th May 20123:07 pmRNSForm 8.3 - QUINDELL PORTFOLIO PLC
10th May 201212:05 pmRNSForm 8 (DD) - Quindell Portfolio PLC
9th May 201211:49 amRNSForm 8.3 - QUINDELL PORTFOLIO PLC
9th May 201211:44 amRNSForm 8 (DD) -Quindell Portfolio
9th May 20127:00 amRNS£120 Million Contract Win
8th May 201212:15 pmRNSForm 8 (DD) - Quindell Portfolio plc
4th May 201210:38 amRNSForm 8 (DD) - Quindell Portfolio
3rd May 201210:20 amRNSForm 8 (DD) - Quindell Portfolio PLC
2nd May 201210:37 amRNSForm 8 (DD) - Quindell Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.